Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00869206 · BASELINE

Baseline characteristics

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement · Source last updated 2018-11-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      911
    2. group Id
      BG001
      value
      911
    3. group Id
      BG002
      value
      1822
    units
    Participants
groups
  1. description
    Patients receive zoledronic acid IV over at least 15 minutes every 4 weeks for up to 2 years in the absence of disease progression or unacceptable toxicity.
    id
    BG000
    title
    Arm I (Zoledronic Acid Every 4 Weeks)
  2. description
    Patients receive zoledronic acid IV over at least 15 minutes every 12 weeks for up to 2 years in the absence of disease progression or unacceptable toxicity.
    id
    BG001
    title
    Arm II (Zoledronic Acid Every 12 Weeks)
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          12.1
          value
          65.3
        2. group Id
          BG001
          spread
          11.7
          value
          65.3
        3. group Id
          BG002
          spread
          11.9
          value
          65.3
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          414
        2. group Id
          BG001
          value
          428
        3. group Id
          BG002
          value
          842
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          497
        2. group Id
          BG001
          value
          483
        3. group Id
          BG002
          value
          980
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          911
        2. group Id
          BG001
          value
          911
        3. group Id
          BG002
          value
          1822
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
population Description
All baseline patients demographics were analyzed.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      911
    2. group Id
      BG001
      value
      911
    3. group Id
      BG002
      value
      1822
    units
    Participants
groups
  1. description
    Patients receive zoledronic acid IV over at least 15 minutes every 4 weeks for up to 2 years in the absence of disease progression or unacceptable toxicity.
    id
    BG000
    title
    Arm I (Zoledronic Acid Every 4 Weeks)
  2. description
    Patients receive zoledronic acid IV over at least 15 minutes every 12 weeks for up to 2 years in the absence of disease progression or unacceptable toxicity.
    id
    BG001
    title
    Arm II (Zoledronic Acid Every 12 Weeks)
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          12.1
          value
          65.3
        2. group Id
          BG001
          spread
          11.7
          value
          65.3
        3. group Id
          BG002
          spread
          11.9
          value
          65.3
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          414
        2. group Id
          BG001
          value
          428
        3. group Id
          BG002
          value
          842
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          497
        2. group Id
          BG001
          value
          483
        3. group Id
          BG002
          value
          980
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          911
        2. group Id
          BG001
          value
          911
        3. group Id
          BG002
          value
          1822
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
population Description
All baseline patients demographics were analyzed.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice